Autonomix Medical CMO receives 2026 CTF Lifetime Achievement Award

Autonomix Medical, Inc. (NASDAQ: AMIX) announced that its co-founder and Chief Medical Officer, Robert Schwartz, M.D., has been named the recipient of the 2026 Cardiovascular Tech Forum Lifetime Achievement Award.

Dr. Schwartz will be honored at Octane's 2026 Cardiovascular Tech Forum on September 18, 2026, in Newport Beach, California. The annual award recognizes individuals for contributions to cardiovascular technology through scientific achievement, clinical innovation, and entrepreneurial leadership.

During his career, Dr. Schwartz has authored more than 500 scientific publications and holds more than 200 patents. He has founded multiple medical technology companies, including co-inventing the Watchman device, which was later acquired by Boston Scientific.

"Rob's career has been defined by a relentless pursuit of innovation that has improved the lives of countless patients around the world," said Brad Hauser, President and Chief Executive Officer of Autonomix.

"I am honored to receive this recognition from the Cardiovascular Tech Forum," said Dr. Schwartz. "Innovation in medical technology has always been driven by collaboration among physicians, engineers and entrepreneurs committed to improving patient outcomes."

Autonomix is a medical device company focused on nerve-targeted treatments. Its technology has not yet received marketing clearance from U.S. regulators.

You May Also Be Interested In

• EShallGo closes $1.75M registered direct offering at $1 per share
• Cosmos Health signs Saudi distribution deal for supplement line
• Vox Royalty agrees to buy two Australian royalties for A$3.4M